Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D01ERB
|
|||
Former ID |
DNC006182
|
|||
Drug Name |
16-(pyridin-4-yl)methylene-estradiol
|
|||
Synonyms |
SCHEMBL12379722
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C24H27NO2
|
|||
Canonical SMILES |
CC12CCC3C(C1CC(=CC4=CC=NC=C4)C2O)CCC5=C3C=CC(=C5)O
|
|||
InChI |
1S/C24H27NO2/c1-24-9-6-20-19-5-3-18(26)13-16(19)2-4-21(20)22(24)14-17(23(24)27)12-15-7-10-25-11-8-15/h3,5,7-8,10-13,20-23,26-27H,2,4,6,9,14H2,1H3/b17-12+/t20?,21?,22?,23-,24-/m0/s1
|
|||
InChIKey |
SOWVSBMETYFGLF-PHKWELIGSA-N
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Estradiol 17 beta-dehydrogenase 1 (17-beta-HSD1) | Target Info | Inhibitor | [1] |
BioCyc | Superpathway of steroid hormone biosynthesis | |||
Estradiol biosynthesis I | ||||
KEGG Pathway | Steroid hormone biosynthesis | |||
Metabolic pathways | ||||
Ovarian steroidogenesis | ||||
NetPath Pathway | FSH Signaling Pathway | |||
Panther Pathway | Androgen/estrogene/progesterone biosynthesis | |||
Pathwhiz Pathway | Androgen and Estrogen Metabolism | |||
Reactome | The canonical retinoid cycle in rods (twilight vision) | |||
WikiPathways | Steroid Biosynthesis | |||
Metabolism of steroid hormones and vitamin D | ||||
Prostate Cancer |
References | Top | |||
---|---|---|---|---|
REF 1 | Modification of estrone at the 6, 16, and 17 positions: novel potent inhibitors of 17beta-hydroxysteroid dehydrogenase type 1. J Med Chem. 2006 Feb 23;49(4):1325-45. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.